sa1084 positive fecal immunochemical test before scheduled surveillance colonoscopy was valuable for...

1
had a longer LOS (mean 8.1(12.8) vs. 7.8(24.3) dys). After adjusting for confounders with linear regression analysis, LOS was still related to weekend presentation (beta=0.1, p=0.007). Conclusion In our population-based cohort of AUGIB, there was no increased mortality or rebleeding rate between weekend vs. weekday presentation despite the observed delay to endoscopy at weekends. Weekend presentation was also found to be associated to an increased LOS. Further studies are required to investigate the potential financial impact of these findings. Comparison of patients with a weekday vs. weekend presentation of acute upper gastrointesti- nal bleeding Data presented as mean (standard deviation) or n (%) as appropriate Sa1082 Color Doppler Ultrasound Is Sensitive Nonionizing Technique to Evaluate Active Crohn's Disease Wataru Shibata, Reiko Kunisaki, Tomohiko Sasaki, Hiroto Kinoshita, Hideaki Kimura, Eiji Miyajima, Kazushi Numata, Shin Maeda Background: Since Crohn's disease (CD) is chronic and multi-focal inflammatory phenotypes, non-ionizing imaging techniques should be considered when evaluating active CD. To avoid the repeated exposure of radiation caused by computed tomography (CT) or small-bowel follow-through (SBFT), we assessed the feasibility of using Color Doppler Ultrasound (CDUS) as a standard non-ionizing/non-invasive technique for evaluating the activity of CD, and predicting the necessity of surgical resection. Methods: Thirty-two histologically proven CD patients, 88 lesions were enrolled (mean age 31.1 years; disease duration 9.2 years ; mean Crohn's disease activity index (CDAI) 198.2; disease behavior: 9 patients small intestine, 24 patients small and large intestine, 23 patients penetrating). The activity of CD was assessed by following variables, including C-reactive protein (CRP), leucocytes and hematocrit and CDAI. We retrospectively evaluated the patients using CDUS, SBFT, and CT before receiving surgical resection. CDUS findings included the evaluation of intra-intestinal active findings such as bowel wall thickness, layer structure, and color Doppler blood flow using Limberg score. Extra-intestinal findings were also assessed by dichotomous variables, including fis- sures, abscess, adhesion, and pseudo-obstruction. Imaging findings and accuracy values of CT, SBFT and CDUS were validated by using surgical specimens considered as gold standard reference. Finally, we analyzed the predictive value of CDUS by assessing the necessity of surgery for new consecutive 76 patients who underwent medical treatment. Results: There was no significant difference regarding the detection rate of active lesions over the three groups; CDUS, SBFT, and CT for any segment of small intestine. Findings found at the time of surgical intervention were as follows; stenosis (21 cases), fissure (9), refractory to medical treatment(9), abscess(1), bleeding(1). Among 88 lesions analyzed, detection rate of intra-intestinal active lesions determined by CDUS were 62%, and CDUS was significantly effective in the detection of extra-intestinal lesions, such as intra-abdominal abscess (CDUS/ SBFT/CT; 100%/0%/100%) and intestinal adhesion (CDUS/SBFT/CT; 33%/0%/0%), respec- tively. Among 4 groups based on two parameters (mucosal layer and color blood flow) of CDUS, the rate of surgical treatment was significantly higher in the group negative for both mucosal layer and color blood flow (90.1%), when compared to the group positive for both (29.2%). Conclusions: CDUS as a standard non-ionizing technique is more sensitive than SBFT or CT for evaluation of the affected small bowel lesions in active Crohn's disease. CDUS may also provide the valuable prediction to determine the need for surgical intervention in patients with irreversible fibrous stenosis that may have caused impaired quality of life. Sa1083 Perioperative Administration of Daikenchuto (TJ-100) Reduces the Postoperative Paralytic Ileus in Patients With Pancreaticoduodenectomy Ken-ichi Okada, Hiroki Yamaue, Masaji Tani, Manabu Kawai, Seiko Hirono, Motoki Miyazawa, Atsushi Shimizu, Yuji Kitahata Objective: The purpose of this study was to clarify whether perioperative administration of Daikenchuto (TJ-100) reduce paralytic ileus after pancreaticoduodenectomy (PD). Summary Background Data: There has been no literature reporting the management of PD with TJ- 100. Methods: Consecutive forty-five patients who had been scheduled to undergo PD at Wakayama Medical University Hospital (WMUH) between August 2010 and August 2011 were registered in this study including first cohort (n=15) as a control group and subsequent cohort (n=30) as a TJ-100 group. This trial was registered at UMIN-CTR ID# 000005056. S-197 AGA Abstracts Results: The postoperative paralytic ileus occurred more frequently in the control group (73.3% of the control group and 20.0% of the TJ-100 group; p=0.001). There was also a significant difference concerning to the incidence of surgical site infection (46.7% and 6.7%; p=0.003). In postoperative course, the first passages of the flatus and normalization of bowel sounds significantly improved earlier in TJ-100 group than those in control group (p=0.014, 0.035). In multiple cytokine assay in the drain fluid and serum, IL-9 and IL-10 in the drain fluid was significantly high level on postoperative day 1 in TJ-100 group. There was no complication related with preoperative administration of TJ-100 before surgery, and concern- ing to postoperative Grade1-2 diarrhea (CTCAE4.0) there was no significant differences between two groups. Conclusion: Perioperative administration of TJ-100 was feasible and reduced the paralytic ileus in PD, and further randomized controlled trial should be needed. Sa1084 Positive Fecal Immunochemical Test Before Scheduled Surveillance Colonoscopy Was Valuable for the Detection of Interval Cancers - A Pilot Study Nozomu Kobayashi, Jun Konishi, Yoshitaka Hirahara, Takahisa Matsuda, Yutaka Saito, Ryuzo Sekiguchi Background and study aims: Surveillance intervals after colonoscopy are recommended based on the findings at the baseline examination. In clinical practice, patients have interval fecal blood test and hasten their visit to hospital, but there is no consensus concerning the necessity of front-loaded colonoscopy sooner than the recommended interval. We investigated whether positive fecal immunochemical test (FIT) before scheduled surveillance colonoscopy was valuable for the detection of interval cancers. Patients and methods: The study included 1260 patients who underwent colonoscopy as a result of FIT, and they were divided into three groups: Group A (n=103), had undergone previous colonoscopy as baseline and the date of next scheduled surveillance was not yet reached; Group B (n=48), had undergone previous colonoscopy as baseline and the date of next scheduled surveillance had passed; and Group C (n=1109), without previous colonoscopy. Ideal surveillance schedules were determined according to the guidelines updated by the US multi-society task force on colorectal cancer in 2012. Advanced adenoma was defined as an adenoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer, and the risk of all neoplastic lesion, advanced adenoma and invasive cancer were compared among three groups. Results: Average age and the rate of male gender were higher in Group B (64.4/49.3 in Group A, 68.6/66.7 in Group B and 63.1/45.1 in Group C; years/ %, respectively). In Group A and B, average intervals from previous colonoscopy were 3.73 and 9.21 years. The incidence of patients with all neoplastic lesions was significantly lower in Group A comparing with the other two groups (33.0%, 56.3% and 51.6%, respectively), and Group A showed significantly lower incidence of patients with advanced adenomas than Group C (8.7%, 16.7% and 19.1%, respectively). In contrast, the incidence of invasive cancer in Group A was lower but not significant (2.9%, 4.2% and 5.0%, respectively). The age- and sex-adjusted odds ratios for all neoplastic lesion, advanced adenoma and invasive cancer in Group A as compared with Group C were 0.45(95 percent confidence interval, 0.29 to 0.69), 0.40 (0.20 to 0.81) and 0.57 (0.17 to 1.85). All of three patients with invasive cancer in Group A had negative findings at baseline colonoscopy and was recommended 10- year interval in theory. Conclusion: Patients with positive FIT before scheduled surveillance colonoscopy have less neoplastic lesions and advanced adenomas. However, their incidence of invasive cancer was not negligible, even in patients with negative findings on baseline colonoscopy. In conclusion, our pilot study suggested that front-loaded colonoscopy as a result of interval positive FIT was valuable for the detection of interval cancers. Sa1085 Improving Outcomes in Severe Pancreatitis With an Acute Care Pancreatitis Protocol Kristin L. MacArthur, Camilia R. Martin, Tyler M. Berzin, Nathan I. Shapiro, Sunil Sheth, Mandeep Sawhney, Alphonso Brown, Steven D. Freedman Background: Severe acute pancreatitis is associated with a higher risk of acute renal failure and increased mortality. Early aggressive fluid resuscitation and enteral or parenteral nutrition within the first 24 to 72 hours of presentation may be the most important intervention to prevent acute organ failure in severe pancreatitis. However, this is not routinely implemented given the multidisciplinary teams involved in these patients. We hypothesized that implemen- tation of a structured management protocol focused on early resuscitation would standardize care, improve renal function, and decrease length of stay. Objective: Determine the effect of a management protocol on renal function and length of stay in patients with severe acute pancreatitis. Methods: We implemented a protocol beginning September 2011 to be used by emergency department (ED) and intensive care unit (ICU) physicians at our hospital for patients with severe acute pancreatitis. The protocol was activated in the ED and consisted of the administration of aggressive crystalloid resuscitation with lab testing every six hours, early nutrition within 24 hours, avoidance of CT scanning, early ERCP if cholangitis was present, and a pancreatology consult. We retrospectively identified 41 patients admitted to the ICU with confirmed severe acute pancreatitis from September 2011 to September 2012. Of these patients, 14 were managed according to the protocol and 37 were managed by the discretion of their physician (controls). Primary outcomes were creatinine change from day one to day three and percent of patients with GFR .60 ml/min/1.73m 2 on day 3 of hospitalization. Secondary outcomes included length of stay and mortality. Patient recruit- ment is ongoing, thus only descriptive data are reported. Results: Protocol patients had a mean creatinine reduction of 0.38 ± 0.16 mg/dl versus a creatinine reduction of 0.02 ± 0.15 mg/dl for the control group over the first three days of admission. By day three, 86% of protocol patients compared to 59% of controls had a GFR .60 ml/min/1.73m 2 . Length of stay was 9.14 days (protocol) compared to 11.3 days (control). No statistical difference was seen in mortality. There was no statistical difference between protocol patients and controls in regards to age, gender, severity (based on BISAP score), or etiology of pancreatitis. Conclusions: Adherence to a strict protocol emphasizing early and aggressive fluid resuscita- tion for patients with severe acute pancreatitis improves renal function and decreases length of stay. These results indicate that despite literature demonstrating improved decreased AGA Abstracts

Upload: ryuzo

Post on 31-Dec-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Sa1084 Positive Fecal Immunochemical Test Before Scheduled Surveillance Colonoscopy Was Valuable for the Detection of Interval Cancers - A Pilot Study

had a longer LOS (mean 8.1(12.8) vs. 7.8(24.3) dys). After adjusting for confounders withlinear regression analysis, LOS was still related to weekend presentation (beta=0.1, p=0.007).Conclusion In our population-based cohort of AUGIB, there was no increased mortality orrebleeding rate between weekend vs. weekday presentation despite the observed delay toendoscopy at weekends. Weekend presentation was also found to be associated to anincreased LOS. Further studies are required to investigate the potential financial impact ofthese findings.Comparison of patients with a weekday vs. weekend presentation of acute upper gastrointesti-nal bleeding

Data presented as mean (standard deviation) or n (%) as appropriate

Sa1082

Color Doppler Ultrasound Is Sensitive Nonionizing Technique to EvaluateActive Crohn's DiseaseWataru Shibata, Reiko Kunisaki, Tomohiko Sasaki, Hiroto Kinoshita, Hideaki Kimura, EijiMiyajima, Kazushi Numata, Shin Maeda

Background: Since Crohn's disease (CD) is chronic and multi-focal inflammatory phenotypes,non-ionizing imaging techniques should be considered when evaluating active CD. To avoidthe repeated exposure of radiation caused by computed tomography (CT) or small-bowelfollow-through (SBFT), we assessed the feasibility of using Color Doppler Ultrasound (CDUS)as a standard non-ionizing/non-invasive technique for evaluating the activity of CD, andpredicting the necessity of surgical resection. Methods: Thirty-two histologically proven CDpatients, 88 lesions were enrolled (mean age 31.1 years; disease duration 9.2 years ; meanCrohn's disease activity index (CDAI) 198.2; disease behavior: 9 patients small intestine,24 patients small and large intestine, 23 patients penetrating). The activity of CD was assessedby following variables, including C-reactive protein (CRP), leucocytes and hematocrit andCDAI. We retrospectively evaluated the patients using CDUS, SBFT, and CT before receivingsurgical resection. CDUS findings included the evaluation of intra-intestinal active findingssuch as bowel wall thickness, layer structure, and color Doppler blood flow using Limbergscore. Extra-intestinal findings were also assessed by dichotomous variables, including fis-sures, abscess, adhesion, and pseudo-obstruction. Imaging findings and accuracy values ofCT, SBFT and CDUS were validated by using surgical specimens considered as gold standardreference. Finally, we analyzed the predictive value of CDUS by assessing the necessity ofsurgery for new consecutive 76 patients who underwent medical treatment. Results: Therewas no significant difference regarding the detection rate of active lesions over the threegroups; CDUS, SBFT, and CT for any segment of small intestine. Findings found at thetime of surgical intervention were as follows; stenosis (21 cases), fissure (9), refractory tomedical treatment(9), abscess(1), bleeding(1). Among 88 lesions analyzed, detection rate ofintra-intestinal active lesions determined by CDUS were 62%, and CDUS was significantlyeffective in the detection of extra-intestinal lesions, such as intra-abdominal abscess (CDUS/SBFT/CT; 100%/0%/100%) and intestinal adhesion (CDUS/SBFT/CT; 33%/0%/0%), respec-tively. Among 4 groups based on two parameters (mucosal layer and color blood flow) ofCDUS, the rate of surgical treatment was significantly higher in the group negative for bothmucosal layer and color blood flow (90.1%), when compared to the group positive for both(29.2%). Conclusions: CDUS as a standard non-ionizing technique is more sensitive thanSBFT or CT for evaluation of the affected small bowel lesions in active Crohn's disease.CDUSmay also provide the valuable prediction to determine the need for surgical interventionin patients with irreversible fibrous stenosis that may have caused impaired quality of life.

Sa1083

Perioperative Administration of Daikenchuto (TJ-100) Reduces thePostoperative Paralytic Ileus in Patients With PancreaticoduodenectomyKen-ichi Okada, Hiroki Yamaue, Masaji Tani, Manabu Kawai, Seiko Hirono, MotokiMiyazawa, Atsushi Shimizu, Yuji Kitahata

Objective: The purpose of this study was to clarify whether perioperative administration ofDaikenchuto (TJ-100) reduce paralytic ileus after pancreaticoduodenectomy (PD). SummaryBackground Data: There has been no literature reporting the management of PD with TJ-100. Methods: Consecutive forty-five patients who had been scheduled to undergo PD atWakayama Medical University Hospital (WMUH) between August 2010 and August 2011were registered in this study including first cohort (n=15) as a control group and subsequentcohort (n=30) as a TJ-100 group. This trial was registered at UMIN-CTR ID# 000005056.

S-197 AGA Abstracts

Results: The postoperative paralytic ileus occurred more frequently in the control group(73.3% of the control group and 20.0% of the TJ-100 group; p=0.001). There was also asignificant difference concerning to the incidence of surgical site infection (46.7% and 6.7%;p=0.003). In postoperative course, the first passages of the flatus and normalization of bowelsounds significantly improved earlier in TJ-100 group than those in control group (p=0.014,0.035). In multiple cytokine assay in the drain fluid and serum, IL-9 and IL-10 in the drainfluid was significantly high level on postoperative day 1 in TJ-100 group. There was nocomplication related with preoperative administration of TJ-100 before surgery, and concern-ing to postoperative Grade1-2 diarrhea (CTCAE4.0) there was no significant differencesbetween two groups. Conclusion: Perioperative administration of TJ-100 was feasible andreduced the paralytic ileus in PD, and further randomized controlled trial should be needed.

Sa1084

Positive Fecal Immunochemical Test Before Scheduled SurveillanceColonoscopy Was Valuable for the Detection of Interval Cancers - A PilotStudyNozomu Kobayashi, Jun Konishi, Yoshitaka Hirahara, Takahisa Matsuda, Yutaka Saito,Ryuzo Sekiguchi

Background and study aims: Surveillance intervals after colonoscopy are recommended basedon the findings at the baseline examination. In clinical practice, patients have interval fecalblood test and hasten their visit to hospital, but there is no consensus concerning the necessityof front-loaded colonoscopy sooner than the recommended interval. We investigated whetherpositive fecal immunochemical test (FIT) before scheduled surveillance colonoscopy wasvaluable for the detection of interval cancers. Patients and methods: The study included1260 patients who underwent colonoscopy as a result of FIT, and they were divided intothree groups: Group A (n=103), had undergone previous colonoscopy as baseline and thedate of next scheduled surveillance was not yet reached; Group B (n=48), had undergoneprevious colonoscopy as baseline and the date of next scheduled surveillance had passed;and Group C (n=1109), without previous colonoscopy. Ideal surveillance schedules weredetermined according to the guidelines updated by the US multi-society task force oncolorectal cancer in 2012. Advanced adenoma was defined as an adenoma that was 10 mmor more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasivecancer, and the risk of all neoplastic lesion, advanced adenoma and invasive cancer werecompared among three groups. Results: Average age and the rate of male gender were higherin Group B (64.4/49.3 in Group A, 68.6/66.7 in Group B and 63.1/45.1 in Group C; years/%, respectively). In Group A and B, average intervals from previous colonoscopy were 3.73and 9.21 years. The incidence of patients with all neoplastic lesions was significantly lowerin Group A comparing with the other two groups (33.0%, 56.3% and 51.6%, respectively),and Group A showed significantly lower incidence of patients with advanced adenomasthan Group C (8.7%, 16.7% and 19.1%, respectively). In contrast, the incidence of invasivecancer in Group A was lower but not significant (2.9%, 4.2% and 5.0%, respectively). Theage- and sex-adjusted odds ratios for all neoplastic lesion, advanced adenoma and invasivecancer in Group A as compared with Group C were 0.45(95 percent confidence interval,0.29 to 0.69), 0.40 (0.20 to 0.81) and 0.57 (0.17 to 1.85). All of three patients with invasivecancer in Group A had negative findings at baseline colonoscopy and was recommended 10-year interval in theory. Conclusion: Patients with positive FIT before scheduled surveillancecolonoscopy have less neoplastic lesions and advanced adenomas. However, their incidenceof invasive cancer was not negligible, even in patients with negative findings on baselinecolonoscopy. In conclusion, our pilot study suggested that front-loaded colonoscopy as aresult of interval positive FIT was valuable for the detection of interval cancers.

Sa1085

Improving Outcomes in Severe Pancreatitis With an Acute Care PancreatitisProtocolKristin L. MacArthur, Camilia R. Martin, Tyler M. Berzin, Nathan I. Shapiro, Sunil Sheth,Mandeep Sawhney, Alphonso Brown, Steven D. Freedman

Background: Severe acute pancreatitis is associated with a higher risk of acute renal failureand increased mortality. Early aggressive fluid resuscitation and enteral or parenteral nutritionwithin the first 24 to 72 hours of presentation may be the most important intervention toprevent acute organ failure in severe pancreatitis. However, this is not routinely implementedgiven themultidisciplinary teams involved in these patients.We hypothesized that implemen-tation of a structured management protocol focused on early resuscitation would standardizecare, improve renal function, and decrease length of stay. Objective: Determine the effectof a management protocol on renal function and length of stay in patients with severe acutepancreatitis. Methods: We implemented a protocol beginning September 2011 to be usedby emergency department (ED) and intensive care unit (ICU) physicians at our hospital forpatients with severe acute pancreatitis. The protocol was activated in the ED and consistedof the administration of aggressive crystalloid resuscitation with lab testing every six hours,early nutrition within 24 hours, avoidance of CT scanning, early ERCP if cholangitis waspresent, and a pancreatology consult. We retrospectively identified 41 patients admitted tothe ICU with confirmed severe acute pancreatitis from September 2011 to September 2012.Of these patients, 14 were managed according to the protocol and 37 were managed bythe discretion of their physician (controls). Primary outcomes were creatinine change fromday one to day three and percent of patients with GFR .60 ml/min/1.73m2 on day 3 ofhospitalization. Secondary outcomes included length of stay and mortality. Patient recruit-ment is ongoing, thus only descriptive data are reported. Results: Protocol patients had amean creatinine reduction of 0.38 ± 0.16 mg/dl versus a creatinine reduction of 0.02 ± 0.15mg/dl for the control group over the first three days of admission. By day three, 86% ofprotocol patients compared to 59% of controls had a GFR .60 ml/min/1.73m2 . Lengthof stay was 9.14 days (protocol) compared to 11.3 days (control). No statistical differencewas seen in mortality. There was no statistical difference between protocol patients andcontrols in regards to age, gender, severity (based on BISAP score), or etiology of pancreatitis.Conclusions: Adherence to a strict protocol emphasizing early and aggressive fluid resuscita-tion for patients with severe acute pancreatitis improves renal function and decreases lengthof stay. These results indicate that despite literature demonstrating improved decreased

AG

AA

bst

ract

s